Table 1.
Characteristic | All Participants (n = 308) |
Participants With Ocular HSV Recurrence (n = 44) |
||||
---|---|---|---|---|---|---|
No. | % | Median (IQR) | No. | % | Median (IQR) | |
Age at randomization, years | 49 (37–63) | 54 (38–65) | ||||
Female gender | 147 | 48 | 22 | 50 | ||
Race/ethnicity | ||||||
White | 263 | 85 | 41 | 93 | ||
African-American | 20 | 6 | 1 | 2 | ||
Othera | 25 | 8 | 2 | 5 | ||
Acyclovir treatment group | 155 | 50 | 23 | 52 | ||
Study center location | ||||||
New Orleans, Louisiana | 33 | 11 | 5 | 11 | ||
Houston, Texas | 21 | 7 | 2 | 5 | ||
San Francisco, California | 61 | 20 | 5 | 11 | ||
Atlanta, Georgia | 66 | 21 | 10 | 23 | ||
Chicago, Illinois | 44 | 14 | 8 | 18 | ||
Milwaukee, Wisconsin | 37 | 12 | 6 | 14 | ||
Philadelphia, Pennsylvania | 21 | 7 | 6 | 14 | ||
New York, New York | 25 | 8 | 2 | 5 | ||
No. of prior HSV recurrencesb | ||||||
Ocular | 4 (1–5) | 3 (2–6) | ||||
Nonocular | 5 (0–11) | 0 (0–9) |
Abbreviations: HSV, herpes simplex virus; IQR, interquartile range.
a Includes persons who reported their race/ethnicity as Asian (2 cases, 18 in total) or Hispanic (no cases, 7 in total).
b Numbers of prior recurrences of HSV were self-reported at study enrollment.